The role of general nuclear medicine in breast cancer
- Faculty of Health, Wheeling Jesuit University, Wheeling, West Virginia (United States)
The rising incidence of breast cancer worldwide has prompted many improvements to current care. Routine nuclear medicine is a major contributor to a full gamut of clinical studies such as early lesion detection and stratification; guiding, monitoring, and predicting response to therapy; and monitoring progression, recurrence or metastases. Developments in instrumentation such as the high-resolution dedicated breast device coupled with the diagnostic versatility of conventional cameras have reinserted nuclear medicine as a valuable tool in the broader clinical setting. This review outlines the role of general nuclear medicine, concluding that targeted radiopharmaceuticals and versatile instrumentation position nuclear medicine as a powerful modality for patients with breast cancer.
- OSTI ID:
- 22402366
- Journal Information:
- Journal of Medical Radiation Sciences (Print), Vol. 62, Issue 1; Other Information: PMCID: PMC4364807; PMID: 26229668; OAI: oai:pubmedcentral.nih.gov:4364807; Copyright (c) 2015 The Authors. Journal of Medical Radiation Sciences published by Wiley Publishing Asia Pty Ltd on behalf of Australian Institute of Radiography and New Zealand Institute of Medical Radiation Technology.; This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.; Country of input: International Atomic Energy Agency (IAEA); ISSN 2051-3895
- Country of Publication:
- Australia
- Language:
- English
Similar Records
Cancer genomics predicts disease relapse and therapeutic response to neoadjuvant chemotherapy of hormone sensitive breast cancers
Collimator design for a dedicated molecular breast imaging-guided biopsy system: Proof-of-concept